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Genomic instability in mutant p53 cancer cells
upon entotic engulfment
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John Le Quesne1,2,9 & Patricia A.J. Muller1,3
Cell-in-cell (CIC) structures are commonly seen in tumours. Their biological signiﬁcance
remains unclear, although they have been associated with more aggressive tumours. Here we
report that mutant p53 promotes CIC via live cell engulfment. Engulfed cells physically
interfere in cell divisions of host cells and for cells without p53 this leads to host cell death. In
contrast, mutant p53 host cells survive, display aberrant divisions, multinucleation and tri-
polar mitoses. In xenograft studies, CIC-rich p53 mutant/null co-cultures show enhanced
tumour growth. Furthermore, our results show that CIC is common within lung adeno-
carcinomas, is an independent predictor of poor outcome and disease recurrence, is asso-
ciated with mutant p53 expression and correlated to measures of heterogeneity and genomic
instability. These ﬁndings suggest that pro-tumorigenic entotic engulfment activity is asso-
ciated with mutant p53 expression, and the two combined are a key factor in genomic
instability.
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There has been a recent growth in research focusing on cell-in-cell (CIC) structures in tumours, which is starting toprovide new insights into their mechanism of formation
and biological implications. CIC structures represent one viable
cell existing within the membrane of another1, and have been
recognised in human tumour tissues for over a century2. In a key
study, Overholtzer et al.3 described a process of in-cell invasion,
entosis, as a route to non-apoptotic cell death via CIC formation.
At other times, different names have been given to processes
causing CIC including cannibalism4, emperipolesis5, and cell
engulfment6 that subtly differ in which cell is driving the event,
under what circumstances the event is happening and what types
of cells are being internalised. In the context of cancer biology,
CIC formation is a suggested mediator of cell competition, which
could ultimately have either pro-tumorigenic or anti-tumorigenic
consequences7.
CIC structures have been identiﬁed in a number of solid
tumours, including breast, lung, endometrial, pancreatic, skin,
and oral cancers8–13. In effusion and urine cytology, CIC struc-
tures are speciﬁc diagnostic indicators of malignant processes14.
Links between histological grade and CIC have also been
described in breast8 and urothelial carcinoma15. Collectively,
these suggest a pro-tumorigenic association with CIC structures,
but no causal link between CIC and tumour growth or other
phenotypes have yet been shown.
We have chosen lung adenocarcinoma as our model in which
to investigate the potential impact of CIC formation on tumor-
igenesis. Lung cancer remains the leading cause of cancer related
death worldwide16 with adenocarcinoma, the most common type,
accounting for 40% of cases17. CIC structures have been observed
in both small cell lung cancer-derived cell lines and primary giant
cell tumours9,18 but have not been described in lung adeno-
carcinoma, in which their prevalence and clinico-pathological
signiﬁcance is unknown.
Large cohort studies of lung adenocarcinoma have mapped a
number of common driving genomic events19. TP53 mutations
are found in around half of non-small cell lung cancers20 and are
very common in many other tumour types21. The p53 protein is a
tumour suppressor involved in regulating the expression of
hundreds of genes that control a variety of cellular processes
including apoptosis, cell cycle check points and cell senescence22.
When mutated, p53 expression is either lost or a mutant protein
is expressed that has often lost the tumour suppressive functions
of wild-type (WT) p53. More remarkably, these mutant proteins
generally acquire novel functions in promoting tumour growth,
invasion, and chemoresistance. These functions are termed ‘gain-
of-function’ and are independent of any remaining WT p5323.
In this study we discovered that mutant p53 expression could
promote the formation of CIC structures in cell lines and that
mutant p53 status is associated with increased CIC occurrence in
lung adenocarcinoma. We further explored the consequences of
CIC both for the individual cell and for tumours formed as
xenografts in recipient mice. Our results suggest that entotic
engulfment is associated with mutant p53 expression, promotes
tumorigenesis and disease recurrence, and facilitates abnormal
mitotic events, which are linked to genomic instability.
Results
CIC formation is driven by mutant p53 expression. While
generating ﬂuorescent cells to study the differences between
mutant p53 and p53 null cells, we noted that these cells often
interacted with each other and that one cell type often engulfed
the other leading to so called CIC structures. To investigate this in
more detail, we used A431 (p53 273H) cells that were transfected
with either eGFP or mCherry plasmids or CRISPR constructs to
knock out p53. This allowed cells with differing p53 status to be
mixed and co-cultures to be followed in time-lapse microscopy.
CIC structures were visible after 2–5 days of co-culturing and
appeared to be formed via an engulfment process with one cell
engulﬁng around another (Fig. 1a, Supplementary Fig 1a and
Supplementary Movie 1).
Upon close examination, engulfment of our cells displayed
many of the features of the recently described process of entotic
engulfment that relies on cell contractility of the internalised cell
by RhoA and ROCK signaling and cell–cell adhesion through β-
catenin and E-Cadherin3. Treatment of A431 cells with the
ROCK inhibitor Y27632A almost completely abolished engulf-
ment (Fig. 1c). Furthermore, an increased expression of E-
Cadherin and β-catenin on the membrane between the inside cell
and the outer cell was detected (Fig. 1b) that was not seen on the
outside membrane shared with neighbouring cells (Fig. 1b and
Supplementary Fig. 1b, c). Cells that were being engulfed
appeared to be rounded up due to just entering or leaving
mitosis (Supplementary Fig. 1a), which was also observed to
happen in entotic cell engulfment24. Previous reports suggest a
role for glucose starvation in entosis, but lowering glucose levels
did not promote engulfment by mutant p53 cells (Supplementary
Fig. 1d), but rather decreased it. Mutant p53 cells promote
glucose import by regulating the Glut1 receptor25 and glucose
deprivation has been shown to decrease mutant p53 expression26.
These results suggest that mutant p53 cells rely heavily on glucose
for survival suggesting that glucose starvation cannot trigger
entotic engulfment in mutant p53 cells.
Interestingly, A431 cells R273H mutant p53 cells were more
often observed to be the outer ‘host’ cell in the ﬁnal CIC structure
than mutant p53 KO cells (Fig. 1a). This was quantiﬁed by
observing how often an outer cell was green (Fig. 1d, left) or red
(Fig. 1d, right) in different p53 co-culture conditions. p53 null
cells were able to engulf, but when combined with mutant p53 in
heterogeneous populations (co-cultures 2 and 3) mutant p53 cells
were signiﬁcantly more often seen to be the external ‘host’ cell
(Fig. 1d). There was a slight preference for mCherry transfected
cells to engulf eGFP transfected cells, which most likely is due to
variations in colour intensities (compare CIC numbers in KO/KO
conditions between left and right ﬁgure in Fig. 1d). When total
entotic engulfment events in each condition were combined, we
detected a two-fold increase in the total number of CIC in the
heterogeneous populations 2 and 3 compared to the p53 KO
homogeneous population (Fig. 1d). More remarkably, the mutant
p53 homogenous population did not differ much in total
engulfments compared to the KO homogenous population
(Supplementary Fig. 1e). Taken together, mutant p53 cells display
entotic cell engulfment that, similar to entosis, relies on
competition between cells27 with an advantage for mutant p53
cells to engulf ‘weaker’ p53-null neighbours, but not competitor
mutant p53 cells
To verify our A431 results (Fig. 1d) in another cell type, we
created ﬂuorescent mutant p53 expressing H1299 cells (273H) to
co-culture with cells transfected with an empty vector (EV) in
combinations indicated in Fig. 1e, f. As with A431 cells, mutant
p53 status promoted engulfment with heterogeneous populations
showing higher rates of entotic engulfment (Fig. 1d–f, Supple-
mentary Fig. 2c and Supplementary Movie 2). p53 mutations
occur throughout the p53 protein and have been found at nearly
every amino acid28. To study if other p53 mutations also
promoted CIC formation, we generated ﬂuorescent mutant p53
R175H H1299 cells and similarly detected an enhanced engulf-
ment in heterotypic cultures that was not seen in the homotypic
cultures (Fig. 1g and Supplementary Fig. 1h). Transient
transfection of R175H, R248W or R273H (in combination with
mCherry) in A431 p53 KO cells also promoted engulfment,
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compared to cells transfected with mCherry alone, conﬁrming
that different mutant p53 proteins promote entotic engulfment in
a similar background (Supplementary Fig. 1i.)
In order to assess whether WT p53 was able to promote entotic
engulfment, we attempted to express WT p53 in A431 KO cells.
However, in the time frame required to study entosis, WT p53
initiated cell death in a large proportion of cells. We therefore
resorted to using a transcriptionally inactive p53 construct (22/
23) in A431 p53 KO cells, to prevent p53 mediated cell death or
cell senescence. Expression of this variant did not promote entotic
engulfment, but expression of mutant p53 R273H, or other
mutants such as R175H or R248W did signiﬁcantly promote
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entotic engulfment (Supplementary Fig 1i). In addition, HCT116
cells (WT p53) or HCT116 p53 null cells showed much less CIC
structures than HCT116 mutant p53 (mutant 248W) cells
(Fig. 1h), indicating that WT p53 is not promoting entotic
engulfment under normal conditions.
Engulfment was also evident in other cell lines; BxPC3 (Y220C
mutant p53), H358 (p53 null), and H322m (R248L mutant p53)
cell lines (Supplementary Fig 1j), but not in U2OS (WT p53), PC-
9 (WT p53) or A549 (WT p53) (Supplementary Fig. 1j, k).
Interestingly, different cell lines displayed varying degrees of
entotic engulfment capacity dependent on the number of cells
that were plated. A431 cells clearly appeared to engulf best when
more conﬂuent, while BXPC3 cells lost the ability to engulf when
less conﬂuent, making it difﬁcult to compare rates of engulfment
between cell lines directly. However, our results are indicative that
entotic engulfment is not restricted to one particular cell type and
is more common in mutant p53 cell lines.
Entosis is associated with EGFR and integrin expression. To
prove that entotic engulfment was complete and not the result of
cells growing on top of each other, Z-stack images were generated
of CIC structures that conﬁrmed complete enclosure of the
engulfed cell (Fig. 2a). A pH sensitive pHrodo dye29 was shown to
encompass the engulfed cell, further conﬁrming full engulfment
and, in agreement with literature, suggest internalization of the
cell in a lysosomal compartment3 (Fig. 2b). In most cases the
internal cells were alive as Calcein AM staining was visible in
many engulfed cells30 (Fig. 2c) and internalised cells were able to
divide (Fig. 3aii and 3ci).
Our previous work demonstrated a role for mutant p53 in
regulating integrin and epidermal growth factor receptor (EGFR)
signaling to promote invasion and metastasis31. Integrins and
EGFR have been shown to promote the related process of
phagocytosis that occurs in various immune cells to clear
damaged or infected cells32–34. Furthermore, ROCK signaling,
which others and we have shown to be inhibiting entotic
engulfment (Fig. 1c), is a downstream target of integrins35. When
grown on ﬁbronectin, H1299 cells, but not A431 cells, revealed a
small increase in CIC structure formation (Fig. 2d) and integrin
(alpha 5 chain) was found to be high expressed on the cell
membranes that were shared between the engulﬁng and engulfed
cell (Fig. 2e). The involvement of alpha 5 integrins was further
demonstrated by inhibition with a monoclonal antibody (mab16)
against the alpha 5 subunit of integrin in A431 cells or with
mab16 or Y27632 in H1299 (175H and EV) cells (Figs. 1c, 2f, g).
In both cell lines a clear decrease in engulfment was seen upon
integrin or ROCK inhibition. Interestingly, the co-cultures of
H1299 cells furthermore demonstrated that even homotypic
cultures of EV or mutant cells could be inhibited, suggesting that
mutant p53 activates engulfment through integrin activation.
Similar to integrin inhibition, EGFR inhibition, with geﬁtinib,
resulted in a decrease in entotic engulfment of both mutant p53
cells and p53 null A431 cells (Fig. 2i). Conversely EGF treatment
promoted the number of CIC structures in both co-cultures more
than 3-fold (Fig. 2h), indicating that entotic engulfment can be
induced by EGF in a mutant p53-independent manner. Increased
CIC formation coincided with an increased phosphorylation of
EGFR that, in agreement with our previous work31, was more
pronounced in mutant p53 cells than in p53 null cells (Fig. 2j).
Together these data suggest a role for mutant p53 mediated
activation of integrins and EGFR in cell engulfment.
CIC formation disturbs cell division of the host cell. In order to
understand what the consequences of mutant p53 driven entotic
engulfment are for a cell, we monitored co-cultures of our control
R273H mutant p53 A431 and CRISPR p53 KO A431 cells. A431,
as opposed to H1299 cells, were used as they engulf more fre-
quently and at much lower conﬂuency, which is more suitable to
view in 2D time-lapse imaging. Three different outcomes for the
engulfed internal cell were seen: escape (Fig. 3a left and Supple-
mentary Movie 3), cell division (Fig. 3a middle and Supplemen-
tary Movie 4) or cell death (Fig. 3a right, Supplementary
Movie 5). As escape often followed division of the internal cell,
these outcomes were quantiﬁed together as surviving cells
(Fig. 3b). Both mutant p53 and p53 null cells survived about half
of all events, regardless of the status of the outside cell (Fig. 3b),
suggesting that the outside cell status does not dictate the fate of
the inside cell. Three different outcomes for the host cell were
noted: normal division (Fig. 3c left top, Supplementary Movie 3),
death (Fig. 3c left bottom, Supplementary Movie 6) and aberrant
divisions (Fig. 3c right, Supplementary Movie 7). The number of
normal divisions was similar in all conditions (Fig. 3d left). Most
strikingly, cell death was almost three times higher in p53 null
host cells than mutant p53 host cells that were both engulﬁng p53
KO cells (Fig. 3d middle). Notably, this cell death did not always
lead to death of the internal cell, which sometimes escaped.
Conversely to cell death, aberrant divisions were seen three times
more often in mutant p53 host cells than p53 KO host cells
engulﬁng p53 KO cells (Fig. 3d right). Mutant p53 cells engulﬁng
neighbouring mutant p53 cells were more likely to undergo failed
division, but less frequently than a mutant p53 cell engulﬁng a
p53 KO cell (Fig. 3d right). Similarly, the number of dying host
cells was less than p53 KO cells, but more than mutant p53 cells
engulﬁng a p53 KO cell. In conclusion, these data suggest that the
Fig. 1 CIC occurrences are predominantly seen in mutant p53 cells. a Confocal images of CIC formed in A431 with a CRISPR control plasmid (Ctr 273H) or
CRISPR p53 knock out (KO 273H) cells (in addition to ﬂuorescent constructs as indicated). Arrows indicate CIC, p53 (yellow), nuclei (Dapi). Scale bars=
100 μm. b Immune ﬂuorescent staining of β-Catenin (left) or E-Cadherin (right) in green, p53 in red and Dapi in blue. Scale bars= 50 μm. c Number of CIC
events in mutant p53 (green)/KO p53 (red) co-cultures in which engulfment was quantiﬁed with or without Y27632 (5 μM) after 48 h. Each bar
represents +/−SEM of triplicate experiments ****p < 0.0001. d Quantiﬁcation of CIC in A431 cells. Co-cultures were seeded in the following combinations;
1: KO 273H/mCherry with KO 273H/eGFP, 2: KO 273H/eGFP with Ctr 273H/mCherry, 3: Ctr 273H/eGFP with KO 273H/mCherry and 4: Ctr 273H/eGFP
with Ctr 273H/mCherry. Total numbers of CIC occurrences are shown where the outer engulﬁng cell is green (left graph) or red (right graph). Each bar
represents +/−SEM of triplicate experiments ****p < 0.0001. e Quantiﬁcation of CIC in four different co-cultures of H1299 cells transfected with EV or
273H along with eGFP or mCherry; 1 EV/eGFP with EV/mCherry, 2 EV/eGFP with 273H/mCherry, 3 EV/mCherry with 273H/eGFP and 4 273H/eGFP
with 273H/mCherry. Graphs show CIC with occurrences for each condition based on whether the outer engulﬁng cell was green or red as indicated by
cartoons in the legend. Error bars represent SEM of triplicate experiments **p= 0.0011, ***p= 0.0002 ****p < 0.0001. f Confocal images of CIC (indicated
with arrows) in green H1299 cells (transfected with R273H mutant p53 and eGFP) and red H1299 cells (transfected with EV and mCherry). Nuclei (DAPI)
in blue. Scale bars= 50 μm. g Same as e, but with the 273H mutant p53 H1299 cell lines replaced with 175H mutant p53. Each bar represents +/−SEM of
triplicate experiments *p= 0.048, **p= 0.008 h Percentage engulfment in HCT116 null, WT or mutant p53 R248W cells. Each bar represents +/−SEM of
triplicate experiments *p= 0.016 (null vs R248W) or p= 0.012 (WT vs R248W)
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increased CIC that was seen in heterogeneous mutant p53/p53
null cell populations is at least to an extent caused by increased
death of p53 null cells upon engulfment and survival of p53
mutant cells.
Remarkably, cell death of p53 null cells almost always followed
a failed division of a p53 KO host (Fig. 3e and Supplementary Fig.
2a, Supplementary Movie 8), whereas mutant p53 hosts were
much more likely to complete and survive the event (Fig. 3f,
Supplementary Fig. 2b), especially when the internal cell was a
p53 KO cell. Interestingly, many of these failed divisions lead to
multinucleation (Supplementary Fig. 2b) and subsequent tripolar
mitosis (Fig. 3f, Supplementary Movie 9). Notably, tripolar
mitosis was only seen in multinucleated cells and was conﬁrmed
using tubulin staining to indicate the three centrosomes (Fig. 3g).
Remarkably, tripolar mitosis did result in viable daughter cells
and daughter cells were themselves seen to undergo a further
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round of tripolar mitosis (Fig. 3f, Supplementary Movie 9). These
results prompted us to test the inherent rate of tripolar mitosis in
A431 cells. Of all cell divisions, only 1% of the non-engulﬁng
mutant p53 A431 cells divided as a tripolar mitosis and no
tripolar mitoses were seen in p53 KO A431 cells (Fig. 3h left). Of
all dividing host A431 cells, that had a cell internalised for at least
60 min prior to that disrupted a previous division, 32% of mutant
p53 host cells compared to 5% of p53 null host cells underwent
tripolar mitosis (Fig. 3h right). This suggests that tripolar mitosis
is caused by engulfment and not just related to mutant p53
expression. Interestingly, we also observed tripolar mitosis in
mutant p53 patient tumours and cell lines that had particularly
high numbers of CIC structures (Supplementary Fig. 2c, d).
Together, these data suggest that the increased numbers of CIC
structures are correlated to an increased ability of cells to survive
cell division after entotic engulfment, which was mostly observed
in mutant p53 cells that had engulfed p53 null cells.
CIC in mice is associated with enhanced tumour growth.
Previous studies involving CIC often showed an association
between CIC and tumour aggressiveness8–13, but to our knowl-
edge, the effects of CIC on tumour growth have not been char-
acterized in a carefully controlled animal study. We therefore
hypothesized enhanced growth of tumours with increased CIC.
Our H1299 cell model of lung adenocarcinoma with and without
mutant p53 in combinations similar to those in Fig. 1, provided
the ideal model to test this. We injected eight nude mice with the
four different H1299 co-culture mixtures (EV or R273H with
GFP or mCherry) and monitored tumour progression. We
measured tumour size, CIC structures and p53 status and iden-
tiﬁed CIC structures within the tumours (Fig. 4a, b) to similar
extents as our tissue culture experiments (Fig. 1c) showing that
cells retain their CIC formation ability in vivo. Most interestingly,
tumours with the highest CIC numbers also had the largest
average tumour size (Fig. 4c). Previous studies implicate mutant
p53 expression with increased proliferation, decreased cell death,
and tumour growth36,37. However, in agreement with our pre-
viously published H1299 xenograft studies31, homogenous
mutant p53 expression in H1299 cells did not impact on the
ability of the primary xenograft tumours to grow (co-culture
group 1 compared to group 4, Fig. 4b, c). H1299 mutant p53 and
EV control cells were thoroughly tested for cell cycle progression
and did not show differences in the incorporation of EdU
(Supplementary Fig. 3a), suggesting that just mutant p53 in our
H1299 cells does not promote proliferation or tumour growth.
These data therefore suggest that the increased growth we
observed in co-culture groups 2 and 3 is related to the increased
ability of mutant p53 cells to survive engulfment and not an effect
of mutant p53 on proliferation. Notably, co-culture group 3
results were slightly lower than group 2, which could possibly be
explained by a lower number of p53 expressing cells (Supple-
mentary Fig. 3b). Most CIC structures were detected on the
borders of p53 positive and p53 negative areas of cells (Fig. 4d),
which suggests a preference for CIC formation to take place in
more heterogeneous populations, such as seen in our mutant p53/
p53 null co-cultures (Fig. 1). Notably, tripolar mitoses were also
observed in these xenograft tumours (Fig. 4e).
To asses whether CIC structures occur in genetically
engineered mouse models of p53, we turned our attention to
the KPC mice in which mutant p53 R172H (equivalent to human
R175H) is expressed in combination with a K-Ras12D activating
mutation under a pdx1 promoter conﬁning expression to the
pancreas. Tumours of mutant p53 Pdx1-Cre; LSL-KrasG12D/+;
LSL-Trp53R172H/+ mice are highly metastatic compared to Pdx1-
Cre; LSL-KrasG12D/+; Trp53ﬂox/+mice38 that are known to
invariantly undergo LOH of p53 and are therefore considered
to be p53 null. CIC structures were detected more frequently in
the pancreatic tumours of mutant p53 but not in the p53 null
mice (Fig. 4f, g)38. Interestingly, tripolar mitoses in CIC structures
were often observed in the mutant p53 mice and not in the p53
null mice (Fig. 4g, right hand panel).
Together, these data conﬁrm that entotic engulfment is related
to p53 mutation status and suggest a pro-tumorigenic function
for the engulfment event.
CIC in lung adenocarcinoma is related to poor outcome. We
next investigated a role for CIC in correlation with mutant
p53 status in patient samples. Mutation of p53 is the most ubi-
quitous driving genomic event in pulmonary adenocarcinoma19,
and is highly pleomorphic in its effects upon cellular biology23.
We therefore ﬁrst established a cohort of 273 resected surgical
lung adenocarcinomas (Supplementary Table 1) and counted CIC
events (Fig. 5a) in whole tumour sections. 45% showed CIC and
55% did not. CIC events are highly signiﬁcantly associated with
mitoses (p < 0.0001) and the presence of multinucleation/giant
cells (p < 0.0001) (Fig. 5b, c left). Multinucleated cells were often
seen to be engulﬁng other cells, further suggesting a possible
causative link between entotic engulfment and multinucleation
(Fig. 5c right). There are also highly signiﬁcant associations with
measures of nuclear grade including nuclear membrane irregu-
larity, (p < 0.0001), nuclear size (p < 0.0001) and nucleolar size (p
< 0.0001) (Fig. 5d) and with high-risk histological patterns of
disease (Fig. 5e). Furthermore, tumours with observable CIC are
strongly associated with earlier recurrence (Fig. 5f) and death
(Fig. 5g). This association was preserved in a multivariate Cox
model of tumour recurrence (HR= 1.98, p= 0.025) including
Fig. 2 Cell surface molecules regulated by mutant p53 are involved in CIC formation. a 3D images of a CIC structure in H1299 cells. The top right insert is
showing the horizontal plane by confocal imaging. Scale bar= 5 μm. b Fluorescent image of live A431 cells that have been labeled with pHrodo. Scale bars
= 50 μm. c Confocal image of A431 cells that have been stained with Calcein AM. Scale bars= 20 μm. d Quantiﬁcation of CIC for H1299 co-cultures
seeded on plastics coated with different matrices. Each bar represents +/−SEM of triplicate experiments **p= 0.0072. e Immunoﬂuorescence image of a
CIC structure formed between H1299 cells (green and red as indicated). Dapi is in blue and CD49e (integrin α5) is in yellow. Scale bar= 50 μm. f Number
of CIC events in mutant p53 (green)/KO p53 (red) A431 co-cultures in which engulfment by red cells was quantiﬁed in the presence of mAb16. Each bar
represents +/−SEM of triplicate experiments **p= 0.003. g Quantiﬁcation of CIC in H1299 EV/H1299 175H co-cultures in the presence or absence of
Y27632 or mAb16. Each bar represents +/−SEM of triplicate experiments *p= 0.01–0.04. h Quantiﬁcation of total CIC structures per 20 hpf observed in
A431 Ctr 273H/mCherry and KO 273H/GFP co-cultures treated with and without EGF for 24 h. Either red or green engulﬁng cells were quantiﬁed for KO
273H or ctr 273H respectively. Each bar represents +/−SEM of triplicate experiments Each bar represents +/−SEM of triplicate experiments *p= 0.03 or
**p= 0.004. i Quantiﬁcation of total CIC structures per 20 hpf observed in A431 Ctr 273H/mCherry and KO 273H/GFP co-cultured cells treated with and
without Geﬁtinib (24 h). Either red or green engulﬁng cells were quantiﬁed for KO 273H or ctr 273H respectively Each bar represents +/−SEM of triplicate
experiments **p= 0.0019. j Western blot showing pEGFR and EGFR following treatment of A431 control and p53 CRISPR KO cells, with and without
Geﬁtinib and EGF. Actin was used as loading control
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known major predictors of early relapse, indicating statistical
independence (Supplementary Table 2). Together, these ﬁndings
show that CIC structures are common in lung adenocarcinoma,
and are associated with tumour grade, virulence, and poor out-
come. Using tissue microarrays (TMAs) constructed from our
cohort we applied an immunohistochemical assay for p53 protein
overexpression (Fig. 5h), which is an indicator of oncogenic
activating mutations39. A cutoff was optimized using a subset of
36 tumours with known p53 mutation status in order to max-
imise sensitivity and speciﬁcity of mutation detection (90% and
84% respectively). There was a signiﬁcant relationship between
mutant p53 expression and the occurrence of CIC (Fig. 5i).
Furthermore, on closer examination we also observed that CIC
occurrences peak when numbers of mutant p53-positive cells are
a b
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intermediate (Fig. 5j). This implies that at very low or very high
proportions of mutant p53 positivity, CIC events are relatively
rare, suggesting that p53 heterogeneity is linked to higher rates of
cellular engulfment, supporting our data in heterogenous cell
populations in vitro (Fig. 1) and our mice data (Fig. 4d).
CIC is associated with DNA damage and genomic instability.
The observation of aberrant mitoses in p53 mutant host cells
suggests a link between p53 mutation, cell engulfment, and cell
division checkpoint escape. Several checkpoint proteins are
involved in maintaining chromosome integrity during cell divi-
sion. One of these is p-Chk1, which is recruited to the DNA to
signal replication stress and has previously been shown to be
regulated by mutant p5340. On several occasions, we could spe-
ciﬁcally detect p-Chk1 on the DNA of engulﬁng A431 cells
(Fig. 6a), but never in the normal cell population grown under the
same conditions. These data suggest that engulfment causes
replication stress that is more detrimental to p53 null cells than it
is to mutant p53 cells. To prove that replication stress survival is
dependent on mutant p53 induced Chk1 activation, we blocked
phosphorylation using TCS231241,42. TCS2312 treatment indeed
led to a reduction in the number of CICs detected in mutant p53
cells (Fig. 6b).
Given these associations between CIC, aberrant mitosis and
replication stress, we sought evidence that CIC is related to
chromosomal abnormalities in human tumour tissue. For this
purpose, we quantiﬁed CIC in digital images of tumour sections
from the TRACERx cohort, examining a set of 100 human non-
small cell lung cancers43. These tumours had previously been
subjected to multiregion whole-exome sequencing, enabling
quantiﬁcation of somatic single nucleotide and copy number
variants, as well as measures of genomic intratumour hetero-
geneity. We identiﬁed a trend (p= 0.064) towards increased
frequency of CIC structures in patients with p53 mutations
(Fig. 6c). Furthermore, CIC was highly signiﬁcantly associated
with structural chromosomal changes as measured by weighted
genome integrity index (wGII) when considering all patients
(ALL) (Fig. 6d left). This association was slightly stronger in lung
adenocarcinomas (LUAD) (Fig. 6d right). Crucially there was no
relationship with single nucleotide variants (Supplementary
Fig. 4a), suggesting that any causal link between CIC and
genomic alteration is related to chromatin structural aberration
rather than sequence changes. Furthermore, while CIC was not
associated with the amount of clonal copy number alterations
(Supplementary Fig. 4b), a signiﬁcant association was found
between CIC and both the overall amount of subclonal copy
number alterations (Fig. 6e), and the percent subclonal copy
number alterations (Fig. 6f).
Discussion
Although CIC structures have been described in histological
sections of solid tumours for decades9,18, we still know remark-
ably little about their physiological or clinical relevance. In this
work, we have shown highly signiﬁcant relationships between
CIC and patient outcome as well as architectural and cytological
measures of tumour grade. We suggest that quantiﬁcation of CIC
may be a useful component of prognostic lung cancer grading
systems, which are nearing routine clinical implementation. CIC
therefore merits further investigation as a prognostic biomarker
in this regard.
The origin of multinucleate cells in tumours is unclear, with
cell fusion and failure of cytokinesis in mitosis both being
possible44,45. In our system, the associations between CIC and
multinuclearity, in human tumours, and the observed link
between CIC and multinucleation in cell culture, strongly sup-
ports a model in which entotic engulfment induces multi-
nuclearity by interfering with cytokinesis.
We detected a highly signiﬁcant association between CIC event
frequency and mutant p53 expression. Although CIC ascribed to
entosis has been related to molecular markers such as E-Cadherin
and K-Ras in tissue culture46, no association with speciﬁc geno-
mic changes has previously been demonstrated. Crucially we
show in cell culture that mutant p53 expression is sufﬁcient to
greatly enhance the cellular engulfment process which leads to
CIC structures, strongly supporting a causative mechanistic link
between p53 mutation and CIC in tumour tissue. Our results
raise the question as to what mechanism(s) underlie entotic
engulfment. This is likely to be complex, given the numerous
receptor-triggered pathways leading to cell engulfment in classical
phagocytosis47. However, in line with our previous work on
mutant p53 function in invasion and metastasis, we have pro-
vided evidence that EGFR and alpha5/beta1 integrin and ROCK
signaling are involved. Future studies will employ screens to
identify whether other receptors and cell signaling molecules are
involved.
The associations between CIC and both patient outcome and
tumour grade show that cellular entotic engulfment is an indi-
cator of tumour virulence. We found that p53 null cells often die
after engulﬁng other cells. In contrast, mutant p53 cells which
engulf others and in particular p53 null cells generally survive,
and often go on to survive failed mitotic events resulting in
multinucleation and tripolar mitotic events (Fig. 7). p53 has well-
Fig. 3 Mutant p53 status determines CIC outcomes. a Fluorescent time-lapse images illustrating the internal A431 cell outcomes. Arrows indicate the
internal cell that is either escaping (top), dividing (middle) or dying (bottom). Scale bars= 50 μm. (also see Supplementary Movies 3–5) b Quantiﬁcation
of CIC outcomes for the internal cell, death or survival, based on the host cell p53 status. Each bar represents +/−SEM of three sets of 20 videos.
c Fluorescent time-lapse images illustrating host cell outcomes in which arrows indicate activity of the host cell including normal division (top, please note
that this is part of the same video as for 3ai), death (bottom) or aberrant division (right). Scale bars= 50 μm. Events indicated with arrows. (also see
Supplementary Movies 3, 6 and 7) d Quantiﬁcation of the host cell outcomes following engulfment. This includes normal cell division (left), death (middle)
*p= 0.0111, **p= 0.0065 and aberrant division (right) *p= 0.0409, **p= 0.0295. Each bar represents +/−SEM of three sets of twenty videos.
e, f Fluorescent and phase contrast time-lapse images of tripolar division events of a e CRISPR KO 273H host and f Ctr 253H mutant p53 host, both of
which engulfed a CRISPR KO 273H internal cell. White arrows indicate daughter cells, blue arrow indicates where a daughter cell survives and
subsequently divides. Scale bars= 50 μm. (please see Supplementary Fig. 2d on this ﬁgure with superimposed nuclei). These time lapses correspond to
Supplementary Movies 8 and 9. g Non-ﬂuorescent A431 mutant p53 cells were stained for tubulin and imaged in a Z-stack with confocal microscopy. Red
arrows indicate an engulfed cell, white arrows indicate spindle formation. Scale bar= 20 μm. h Quantiﬁcation of (left) tripolar mitoses as a percentage of
total mitoses in Ctr 273H A431 or CRISPR KO A431 cells (error bar represents +/−SEM in ten sets of ten videos) and (right) tripolar mitoses of engulﬁng
cells (error bar represents +/−SEM of seven sets of ten videos) as a percentage of total engulﬁng cells undergoing mitosis (n= 100). Error bars indicate
SEM **p= 0.0089
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described roles in ensuring normal segregation of chromosomes
at mitosis, being involved in normal centrosome clustering40 and
in the operation of mitotic checkpoint controls48. Conversely,
mutant oncogenic p53 function is permissive of abnormal mitotic
events, and permits passage through mitotic checkpoints that
would otherwise induce apoptotic cell death of abnormal cells,
causing chromosomal changes49,50.
We show that mutant p53 activated p-Chk1 to survive repli-
cation stress in cells with genomic abnormalities40. Inhibition of
p-Chk1 by others was found most useful in inhibiting growth of
mutant p53 positive tumour xenografts51,52. In addition to this,
engulfment has previously been shown to favour aneuploidy in
subsequent mitoses due to steric interference with the normal
dynamics of cell division by the ingested cell53. This was
accompanied by aberrant gene copy numbers in host upon
entosis53. Therefore the combination of cell ingestion and mutant
p53 status might be expected to drive abnormal mitotic events;
the entotic engulfment event would cause abnormal cellular
division, and p53 mutation would allow the abnormal progeny to
survive. This is what we observe in cell culture.
Crucially, when we sought associations between CIC, p53 and
large-scale genomic aberrations in a set of tumours for which we
also held full genomic characterization, we observed the predicted
association between CIC and somatic copy number aberrations,
but found no association with single nucleotide variants, con-
sistent with a model in which CIC affects chromosome integrity/
segregation but not the ﬁdelity of DNA replication. Interestingly,
chromosomal instability has previously been reported in the
Pdx1-Cre; LSL-KrasG12D/+; LSL-Trp53R172H/+ mice and not the
Pdx1-Cre; LSL-KrasG12D/+38, further supporting the idea that
mutant p53 expression and CIC are associated with genomic
instability.
Although most reports link CIC to pro-tumorigenic effects,
some studies suggest anti-tumorigenic or anti-metastatic prop-
erties for CIC7,11. Our study provides a possible explanation for
this discrepancy based on p53 status; CIC in mutant p53 cells
drives aneuploidy, as described above, but in cells with no or
wild-type p53, the host cells more frequently die (Fig. 7).
Our results also suggest that CIC occurrence is higher in het-
erogeneous populations of cancer cells. Intratumour
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heterogeneity is a crucial issue in cancer diagnosis and treatment,
with the potential for treatment-resistant subclones resulting in
disease relapse. The heterogeneity of the lung cancer has recently
been demonstrated, and at least 80% of cases are detectably
polyclonal54 and subclonality of TP53 mutations in particular
have been described43. In keeping with this, in our IHC assay of
p53 protein expression, the numbers of positively stained nuclei
varied widely from case to case suggesting that in some cases p53
mutation was subclonal (Fig. 5h). Besides heterogeneity due to
genomic clonality, p53 protein expression is a highly responsive
to external stress stimuli, which might also underlie the variation
in p53 IHC staining that we and others can see within one
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tumour. Of particular interest for this study is the ﬁnding that
mechanical stress can induce p53 expression25. When analyzing
CIC structures in different cell lines (Supplementary Fig. 1k), we
noticed that the cell density can greatly affect CIC numbers with
higher densities often leading to more CIC. Hypothetically,
mutant p53 expression mediated regulation of CIC could there-
fore provide a mechanism in crowded tumours to create space for
the most aggressive cells to survive.
Our observations of more frequent CIC occurrences in p53-
heterogeneic populations, in patients, in tissue culture and in
xenografts, support our model in which mutant p53 and CIC
synergise to cause genomic heterogeneity via chromosome
destabilization. Excitingly, this relationship might also be evi-
dence of direct clonal competition, with CIC events representing
a mechanism of interclonal conﬂict. Understanding the
mechanisms underlying CIC is therefore crucial, as inhibition of
CIC might both stabilize cancer cell genomes and reduce the
scope for successful interclonal competition and natural selection
during cancer therapy.
Methods
Archival tissues and morphological scoring. Patient samples were obtained from
the Leicester thoracic tumour archive, a single-centre retrospective cohort study of
surgical lung cancer specimens, with ethical approval from the NRES East Mid-
lands Research Committee (REC reference 14/EM/1159). The set included in this
study contains 994 surgical specimens from primary pulmonary adenocarcinoma
surgeries performed with curative intent in Leicester between 1998 and 2014. Full
clinicopathological data, were recorded for each patient. For this study, we included
273 of the 994 patients that were ﬁrst readily available and complete in terms of full
tumour sections, images and patient data, and the cohort is summarised in Sup-
plementary Table 1.
In brief, diagnostic slides of tumour tissue were recovered from the archive and
digitized (at 40× magniﬁcation) using a Hamatsu Nanozoomer-XR
C12000 scanner (Hamamatsu Photonics Ltd, UK). Ten high power ﬁelds (hpf) of
the scanned images (equivalent to 2.4 mm2) were examined and scored for; mitotic
cells, multinucleated cells, nuclear membrane irregularity (smooth/mild/moderate/
severe), nuclear size (median diameter < 3×/3−5×/>5× lymphocyte diameter),
nucleolar size (small/medium/large/very large) and also predominant disease
growth pattern (low risk, in situ/medium risk, acinar or papillary/high risk, solid or
micropapillary) using H&E staining. For scoring of CIC structures, 10 hpf areas
within epithelial-rich viable malignancy on digital images of tumours were
analysed using NDPView2 software. CIC occurrences were counted within these
areas. To count as a CIC structure, at least four of the six following features were
required to be unequivocally identiﬁable: nucleus of internalised cell, cytoplasm of
internalized cell, nucleus of engulﬁng cell, cytoplasm of engulﬁng cell, ‘moon-
shape’ host nucleus, and intervening vacuolar space. Only events where 100% cell
internalisation was evident were counted.
TRACERx. TRACERx is a prospective cohort study in which primary tumours
collected from patients with stages I-IIA non-small cell lung cancer undergoing
curative resection are subjected to multiregion whole-exome sequencing43. The
study (Clinicaltrials.gov no: NCT01888601) is sponsored by University College
London (UCL/12/0279) and approved by an independent Research Ethics Com-
mittee (13/LO/1546). TRACER is funded by Cancer Research UK (grant number
C11496/A17786) and coordinated through the Cancer Research UK & UCL Cancer
Trials Centre.
The following eligibility criteria were used to recruit patients into the TRACERx
study:
Inclusion criteria: Written Informed consent, Patients ≥18 years of age, with
early stage I-IIIA disease who are eligible for primary surgery, Histopathologically
conﬁrmed NSCLC, or a strong suspicion of cancer on lung imaging necessitating
surgery (e.g., diagnosis determined from frozen section in theatre), primary surgery
in keeping with NICE (National Institute for Health and Care Excellence)
guidelines planned, agreement to be followed up in a specialist centre, ECOG
performance status 0 or 1. Exclusion criteria: Any other current malignancy or
malignancy diagnosed or relapsed within the past 5 years (other than non-
melanomatous skin cancer, stage 0 melanoma in situ, and in situ cervical cancer),
psychological condition that would preclude informed consent, treatment with
neo-adjuvant therapy for current lung malignancy deemed necessary, adjuvant
therapy other than platinum-based chemotherapy and/or radiotherapy, known
human immunodeﬁciency virus (HIV), hepatitis B virus (HBV), hepatitis C virus
(HCV) or syphilis infection, sufﬁcient tissue, i.e., a minimum of two tumour
regions, is unlikely to be obtained for the study based on pre-operative imaging.
Clonal and subclonal copy number alterations and mutations were determined
as described43, wGII scores55 were determined independently for each tumour
region, and averaged across all regions. Association between CIC and genomic
alterations were determined using Spearman Rank Correlation. TP53 was
considered altered if harbouring a known cancer driver mutation, as described43.
Association between CIC and TP53 status was assessed using a Wilcoxon Rank
Test. All sequencing data have been deposited in the European Genome–Phenome
Archive under accession number EGAS00001002247.
Animal models. The project license was granted under the Animals (Scientiﬁc
Procedures) Act 1986. Four groups with eight healthy male mice in each were
subcutaneously injected with cell xenografts. These numbers were predicted to
render signiﬁcant results on tumour growth based on pilot experiments as well as
previous experiments in which we examined tumour growth of H1299 cells31. The
mice were 40+-day-old balb/c nude/male mice (Jackson laboratories), housed at
the Division of Biomedical Services at the University of Leicester in individually
vented cages enriched with tissues and cardboard shelter. Mice were kept on a
standard day/night cycle at ambient room temperature and chow and drinking
water accessible ad libitum. Bias was reduced by random allocation of mice to the
four groups, and blind analysis for the duration of the experiment. Brieﬂy, 100 μl of
cell suspension (containing 5 × 105 H1299 cells in four different combinations) was
combined with 100 μl of Matrigel (356231 Corning). Mice were anaesthetised in
the morning before noon using isoﬂuorane (ﬂowmeter 500/1000 ml/min) as a rapid
induction and recovery anaesthetic with the vaporizer set to 5% until signs of
recumbent. Mice were then placed on a nosecone with the vaporizer set to 1.5%
isoﬂuorane before mice were injected with cells in a sterile hood and placed directly
back into a clean standard housing cage and monitored for the rest of the day.
Subsequently, mice were monitored daily for weight changes, signs of distress or
infection and tumour growth using caliper measurements. We did not note >10%
weight loss, infection or any other adverse events throughout our study. Mice were
culled (using a schedule 1 approved technique of cervical vertebrae dislocation)
when the tumour measurement reached a maximum size of 1200 mm3 as stipulated
in our project license. Following dissection and checks for local and distant
metastasis, excised tumours were ﬁxed in formaldehyde and sections were cut.
Sections were then stained according to standard H&E staining protocols and
scored for CIC, as previously described in FFPE patient samples.
H&E stained slides from pancreatic tumours of Pdx1-Cre; LSL-KrasG12D/+;
Trp53ﬂox/+ and Pdx1-Cre; LSL-KrasG12D/+; LSL-Trp53R172H/+mice were obtained
from Dr Morton (described in ref. 56) and were scanned using the Leica SCN 400.
CIC structures were quantiﬁed as described before.
Tumour DNA extraction and p53 sequencing. Thirty-six 1 mm cores of lung
adenocarcinoma tumour were removed from the FFPE adenocarcinoma blocks.
Excess parafﬁn was removed and remaining tumour placed into a micro centrifuge
tube. DNA was then extracted via the GeneRead DNA FFPE kit (Qiagen, UK)
according to manufactures instructions. Once extracted, DNA was then sequenced
using Ion Torrent Next Generation Sequencing (NGS) technology (Ion Ampli-
SeqTM Colon and Lung Cancer Panel) gain-of function p53 mutations were
identiﬁed by point mutations in the DNA binding region (Supplementary Table 3).
Tissue micro-arrays and p53 immunohistochemistry. TMAs were constructed
with three 1 mm cores of lung adenocarcinoma tumour per patient case, with 60
Fig. 6 CIC correlates with replicative stress and measures of both genomic instability and sub clonal copy number loads in patients. a Z-stack images of
non-ﬂuorescent 273H mutant p53 A431 cells that were stained for pChk1 using immune ﬂuorescence,and imaged with confocal microscopy. Scale bars=
20 μm. b Quantiﬁcation of total CIC structures observed in A431 Ctr 273H/mCherry and KO 273H/GFP co-cultures with and without TCS2312 treatment
for 24 h. Each bar represents +/−SEM of triplicate experiments ****p < 0.0001. c Association between p53 mutations and CIC using the ﬁrst 100 patients
used in the TRACERx study. d–f Associations between CIC and indicators of genomic instability in all the ﬁrst 100 lung cancer patient tumours of the
TRACERx study (ALL) and or lung adenocarcinoma tumours (LUAD) speciﬁcally (n= 61). d Association between CIC and weighted genome integrity index
(wGII) for ALL (left) and LUAD (right). e Association between CIC and genomic alterations using sub clonal copy number loads in NSCLC for ALL (left) and
LUAD (right). f Association between CIC and genomic alterations using percent sub clonal copy number loads in NSCLC for ALL (left) and LUAD (right).
Statistical analysis was Spearman’s rank correlation, with rho and p values indicated on the graphs
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cases on each slide. Two consecutive TMA sections were stained for p53 (Dako
DO-7) and cytokeratin AE1/AE3 (Dako) using an Agilent™ Link 48 instrument
following antigen retrieval in a PT Link unit, following manufacturer’s recom-
mendations. Counterstained slides were then scanned using a Nanozoom XR
C12000 digital slide scanner and analysed with Visiopharm analysis software
applications. Brieﬂy, p53 and cytokeratin stained cores were aligned and, nuclei
within cytokeratin-positive areas were identiﬁed. P53-positive nuclei were identi-
ﬁed by the application of a manually optimized threshold, which counted strongly
staining nuclei, and the proportion of positive nuclei was calculated as a percen-
tage. An average for the three cores per case was calculated. Mutational status from
the 36 cases in which this data was obtainable was used for receiver operator curve
(ROC) analysis to set a cutpoint to binarise the mean nuclear positivity variable.
The area under the ROC curve was 92%, and the optimal cutpoint (1.9% positive
cells) was identiﬁed by the Liu method. This cutpoint yielded a sensitivity of 90%
and speciﬁcity of 84%.
For xenograft tumours, a different p53 antibody (1:1000 Dako, Denmark) was
used to perform immunohistochemistry and this was done with an
AutostainerLink48 (Dako).
Cell culture and constructs. A431, A549, U2OS, BxPC-3, and H1299 cell lines
were obtained from ATCC. PC-9, H322m, H358, and H23 cell lines were a kind gift
from Dr. Howard Pringle. HCT116 cells were a gift from Dr Bert Vogelstein. Cell
lines were maintained in Dulbecco’s modiﬁed Eagle’s medium (Gibco, UK) sup-
plemented with 10% foetal bovine serum (Sigma, UK) and 1% pen/strep (Gibco,
UK) at 37 °C with 5% CO2. Cells were regularly checked against mycoplasma.
H1299 cells expressing mutant p53 have been established before31 and were stably
transfected with eGFP and mCherry (Clontech, France) and selected using strin-
gent FACS sorting (BD Aria III). A431 p53 knockout cells were made with a
CRISPR construct pLV-U6g-EPCG with target sequence TCCATTGCTTGG
GACGGCAAGG (Sigma, USA) according to the manufacturer’s protocols and
tested for p53 expression using western blot, where after they were stably trans-
fected with eGFP or mCherry. p53 22/23, 175H, and 273H constructs were
described in ref. 31. R248W mutant p53 was generated using mutagenesis with the
following oligos: fw- TGCATGGGCGGCATGAACCaGAGGCCCATCCT
CACCATC, rev- GATGGTGAGGATGGGCCTCTGGTTCATGCCGCCC
ATGCA.
CIC quantiﬁcation (high content screening). eGFP and mCherry cells were
seeded together in 24-well plates at equal density and left for 48–120 h depending
on the cell line. Before imaging, media was removed, nuclei stained with 10 μM
Hoechst (Molecular Probes, Life Technologies, UK) for 20 min and fresh media
added. Imaging of living cells was done with cellomics high content imaging
(ThermoFisher Scientiﬁc, UK) or the Operetta CLS (Perkin Elmer) at
20× magniﬁcation. Twenty-ﬁve 20× ﬁelds were then analysed for each well to score
for red and green cell engulfment events. If one cell was more than 75% enclosed
within another cell, then this was marked as an engulfment event. Red engulﬁng
red and green engulﬁng green were not counted as these cannot always be con-
ﬁdently detected and classed as background engulfment. Cells were incubated with
1 ng/ml EGF (Sigma), 0.5 μg/ml mAb16 (BD Biosciences), 1 or 5 μM Gefetinib
(Sigma), 250 or 500 nM TCS2312 (Tocris), 5 μM Y-27632 (Merck- Millipore) one
day after seeding until imaging. Plates were coated in 1 μg/cm2 ﬁbronectin (Sigma),
2 μg/cm2 collagen (Sigma) or 1 μg/cm2 gelatin (Sigma).
For transient transfections, A431 p53 KO cells were transfected with a
combination of mCherry (0.2 μg) with the indicated p53 constructs or a pcb6
control (1 μg). In pilot experiments, we determined that >80% of cells that had
incorporated mCherry, also incorporated p53. Engulfment was quantiﬁed based on
the number of red cells engulﬁng neighbours as a percentage of all red cells using
Hoechst as labeling to indicate individual cells. A minimum of 750 cells per
experiment were counted.
For non-ﬂuorescent cells, cells were stained in 4 nM Calcein for 1 h, washed and
stained with 10 μM Hoechst for 20 min. Twenty-ﬁve 20× ﬁelds were analysed for
the typical engulfment features. Engulfment was further conﬁrmed with Calcein
staining. The percentage engufment was corrected for the total number of cells
detected with the Harmony software in each ﬁeld.
Time lapse analysis. For time-lapse experiments, imaging was started 24–72 h
(depending on the cell line) after seeding cells in a 35 mm glass bottom dish
(Mattek, USA) with images taken every 10 min. Imaging was carried out by a
Nikon biostation IMQ microscope (Nikon, UK), with live brightﬁeld and ﬂuor-
escent imaging capabilities. For time-lapse quantiﬁcation of A431 CIC outcomes,
imaging was started 24 h following cell seeding. Random ﬁelds were selected to
determine internalization. For outcome experiments, CIC structures were located
and imaged for 72 h, in both phase contrast and ﬂuorescent channels, to determine
outcome for both host and internal cells.
Immunoﬂuorescence and confocal imaging. Fluorescent cells were co-cultured
on glass coverslips for 48–120 h, before being washed 3× in PBS and ﬁxed with 4%
paraformaldehyde (Thermo Scientiﬁc, USA) for 10 min at 4 °C. Cells were then
washed and coverslips mounted on slides with vectashield mounting medium with
DAPI (Vector Laboratories, USA) and imaged on a confocal microscope (Zeiss
LSM 510 META NLO, Carl Zeiss, Germany). Z-stacks were generated using
optimal intervals.
Non-ﬂuorescent cells were washed after ﬁxation as above with 3× PBS,
permeabilized with 0.5% Triton X-100 in PBS for 1 min, washed 3× PBS and
blocked in 1% bovine serum albumin (BSA) in PBS for 30 min. Cells were then
incubated with primary antibodies (1% BSA/PBS) for 1 h. Antibodies used were;
Cell death of host
(survival or cell death of 
engulfed cell)
p53 null
p53 null
Mutant p53
p53 null
3 viable daughter 
cells
(some 
multinucleated)
Multinucleation
+ escaped cell
Multinucleation
+ engulfed cell
Cell division
Cell division
Anti-tumorigenic
Pro-tumorigenic
Failed
cell division
Failed
cell division
Failed
cell division
Failed
cell division
Fig. 7 Schematic model of the consequences of cell engulfment in mutant p53 and p53 null cells. In p53 null cells, engulfment followed by a failed cell
division, multinucleation, and subsequent cell division most often leads to cell death. Mutant p53 cells that divide following engulfment, failed division, and
multinucleation experience aberrant mitoses, leading to the generation of three daughter cells via tripolar mitoses and further multinucleation
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p53 (1:200, Santa Cruz), mCherry (1:200, Abcam), Integrin (1:100, Abcam),
mAb16 (1:100 BD Biosciences), Tubulin (1:200, Abcam), p-Chk-1 (1:100 Cell
signaling), E-Cadherin (1:2000, Cell signaling), β-Catenin (1:2000 Abcam). Cells
were washed in PBS (3×), and incubated in Alexa 488, 594 or 633 conjugated
secondary antibodies (1:250, Invitrogen) before mounting. For pHrodo (1 μg/ml,
Invitrogen) or CalceinAM (1:2000 Invitrogen, Molecular Pobes, USA), living cell
were stained for 1 h before washing (2× PBS). Calcein AM stained cells were
imaged straight away while pHrodo labeled cells were imaged 24 h later.
Fluorescent intensity of E-Cadherin and β-Catenin was determined using Plot
Proﬁle in Fiji on the average intensity of lines. Imaris was used to create a 3D
structure from a Z-stack made on the confocal microscope.
Western blot. A431 ctr or KO cells were lysed on ice in NP-40 lysis buffer
(100 mM NaCl 100 mM Tris pH8, 1% NP-40) for 15 min. Pellets were discarded
after spinning at max speed for 15 min at 4 °C and supernatant was separated in
SDS-PAGE and transferred onto nitrocellulose membrane. After blocking with 5%
skimmed milk (Marvel, Camlab, Cambridge, UK) in TBS (Santa Cruz)/0.1%
Tween20 (Sigma) for 30 min at RT, the membranes were incubated with primary
antibodies in 5% skimmed milk/TBS-T. The following primary antibodies were
used for western blotting: EGFR (Cell Signaling), pEGFR (Abcam), Actin (Milli-
pore).The blots were washed three times with TBS-T and then incubated with
corresponding IRDye secondary antibodies 680RD or 800CW (Li-Cor, Cambridge,
UK, 0.05 µg/ml). After three times washing with TBS-T protein signals were
visualized using the ODYSSEY Sa infrared system (Li-Cor) and Image Studio
software 2.0 (Li-Cor). Full scans of Western blots are shown in Supplementary
Figure 5.
Cell proliferation rate measurement. EV and mutant p53 H1299 cell line pro-
liferation rates were measured on a ﬂow cytometer following staining with 5-
ethynyl-2′-deoxyuridine (Edu). This was done with a Click-iT EdU Flow Cyto-
metry Assay Kit (Invitrogen, Molecular Probes), according to manufacturers’
instructions. Results were analysed using BD FACS Diva software (version 8.0.1).
Statistics. In the cell culture experiments, statistical comparisons between groups
were made using a non-parametric T test.
For histopathological data and mice xenographs, differences between two
unpaired groups were detected using the non-parametric Mann–Whitney test, and
between multiple groups using the non-parametric Kruskal–Wallis test.
Associations between paired variables were quantiﬁed using Spearman’s rank
correlation. Survival models were constructed using the Cox method. Data were
modeled over a 4-year period, and radiological evidence of recurrence was taken as
the endpoint. The proportional hazards assumption was tested by inspection of
log–log plots. Survival plots were prepared using the Kaplan–Meier method. Prism
6 or 7 (Graphpad) and Stata SE 13 were used for all analyses.
Data availability. Authors can be contacted to provide raw data upon reasonable
request.
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